-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
New Delhi: According to "ThePrint", the Modi government is likely to announce the final guidelines for its Production Linked Incentive Scheme (PLI), which aims to promote domestic production of active pharmaceutical ingredients (API, API).
The government approved the PLI plan in March to reduce India’s dependence on China’s raw materials for the production of important antibiotics, anti-HIV drugs, vitamins and heart drugs.
On June 11, the Central Pharmaceutical Standards Control Organization (CDSCO) led by the Ministry of Health and Family Welfare (CDSCO) led the plan and formulated guidelines.
What is the PLI plan and its possible guiding principlesCpj China Feed Industry Information Network-Based on feed, serving animal husbandry
What is the PLI plan and its possible guiding principlesThe coronavirus outbreak disrupted the supply chain and triggered concerns about the shortage of medicines in India, which triggered the government's move.
In response to short-term and long-term challenges, the central government established a high-level committee in February to monitor the supply of raw materials.
According to the draft guidelines obtained by ThePrint, the selection criteria include manufacturers who can ensure "higher production capacity" and use the latest technology with less pollution (such as "green chemistry, flow chemistry") for production.
Incentives may be divided into four categoriesCpj China Feed Industry Information Network-Based on feed, serving animal husbandry
Incentives may be divided into four categoriesAccording to the final guidelines, the plan may divide the pharmaceutical industry into four parts.
The first part involves the production of "four fermentation-based key starting materials (KSM) products" that are used to make the best-selling antibiotics, including penicillin and clavulanic acid.
The second part involves "10 fermentation-based niche (filling) KSM and API products", including neomycin, gentamicin, vitamin B1, tetracycline, doxycycline and betamethasone.
In the third part, "4 KSM or API products based on chemical synthesis" attracted a reward of 960 crore rupees, each of which will be given a 10% reward.
The last part will attract a reward of 13.
Each player will receive a 10% reward.
